Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials

BACKGROUND: Chlorpromazine (CPZ) remains one of the most common drugs used for people with schizophrenia worldwide, and a benchmark against which other treatments can be evaluated. Quantitative reviews are rare; this one evaluates the effects of chlorpromazine in the treatment of schizophrenia in co...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Adams, Clive Elliott, Rathbone, John, Thornley, Ben, Clarke, Mike, Borrill, Jo, Wahlbeck, Kristian, Awad, A George
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2005
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1274318/
https://ncbi.nlm.nih.gov/pubmed/16229742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-3-15
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki